These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 19240177

  • 1. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B.
    Clin Cancer Res; 2009 Mar 01; 15(5):1741-6. PubMed ID: 19240177
    [Abstract] [Full Text] [Related]

  • 2. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H.
    Ai Zheng; 2005 Sep 01; 24(9):1132-5. PubMed ID: 16159440
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N.
    Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E, Arias FC, Caso Peláez E, Muñoz Molina GM, Sánchez Hernández I, Muguruza Trueba I, Moreno Balsalobre R, Sacristán López S, Gómez Pinillos A, del Val Toledo Lobo M.
    Cancer; 2009 Apr 15; 115(8):1701-12. PubMed ID: 19197998
    [Abstract] [Full Text] [Related]

  • 6. Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients.
    Chen Z, Wang T, Luo H, Lai Y, Yang X, Li F, Lei Y, Su C, Zhang X, Lahn BT, Xiang AP.
    Hum Pathol; 2010 May 15; 41(5):737-44. PubMed ID: 20132963
    [Abstract] [Full Text] [Related]

  • 7. Expression of thymosin beta10 and its role in non-small cell lung cancer.
    Gu Y, Wang C, Wang Y, Qiu X, Wang E.
    Hum Pathol; 2009 Jan 15; 40(1):117-24. PubMed ID: 18789485
    [Abstract] [Full Text] [Related]

  • 8. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Maekawa S, Iwasaki A, Shirakusa T, Enatsu S, Kawakami T, Kuroki M, Kuroki M.
    Anticancer Res; 2007 Jan 15; 27(6A):3735-41. PubMed ID: 17970036
    [Abstract] [Full Text] [Related]

  • 9. High levels of circulating CD34+/VEGFR3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer.
    Qiu H, Cao L, Wang D, Xu H, Liang Z.
    J Obstet Gynaecol Res; 2013 Jul 15; 39(7):1268-75. PubMed ID: 23803010
    [Abstract] [Full Text] [Related]

  • 10. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y, Manabe T.
    Pancreas; 2007 May 15; 34(4):444-51. PubMed ID: 17446844
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M.
    Lung Cancer; 2007 Nov 15; 58(2):205-13. PubMed ID: 17686546
    [Abstract] [Full Text] [Related]

  • 13. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A.
    Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294
    [Abstract] [Full Text] [Related]

  • 14. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
    Tamura M, Oda M, Matsumoto I, Tsunezuka Y, Kawakami K, Ohta Y, Watanabe G.
    Ann Surg Oncol; 2004 Oct 03; 11(10):928-33. PubMed ID: 15383417
    [Abstract] [Full Text] [Related]

  • 15. Quantification of circulating vascular endothelial growth factor receptor-3-positive lymphatic/vascular endothelial progenitor cells.
    Farace F, Taylor M, Rössler J, Loriot Y, Besse B.
    Clin Cancer Res; 2009 Nov 01; 15(21):6740; author reply 6740-1. PubMed ID: 19861445
    [No Abstract] [Full Text] [Related]

  • 16. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
    Li Q, Dong X, Gu W, Qiu X, Wang E.
    Chin Med J (Engl); 2003 May 01; 116(5):727-30. PubMed ID: 12875690
    [Abstract] [Full Text] [Related]

  • 17. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA, Sutherland RL, Williams ED.
    Clin Cancer Res; 2004 Aug 01; 10(15):5137-44. PubMed ID: 15297417
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M.
    Cancer; 2004 Sep 15; 101(6):1364-74. PubMed ID: 15368324
    [Abstract] [Full Text] [Related]

  • 19. Molecular control of lymphatic metastasis.
    Achen MG, Stacker SA.
    Ann N Y Acad Sci; 2008 Sep 15; 1131():225-34. PubMed ID: 18519975
    [Abstract] [Full Text] [Related]

  • 20. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
    Mouawad R, Spano JP, Comperat E, Capron F, Khayat D.
    Eur J Cancer; 2009 May 15; 45(8):1407-14. PubMed ID: 19157860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.